BridgeMD
New treatment option for Temporal Perturbation
Official title Dynamic Causal Modeling of Neuromodulation of Action Speed Via Targeted TMS-EEG
ClinicalTrials.gov ID: NCT07468032
What this study is testing
- What it's testing
- Stroke is a major cause of long-term disability, with cognitive and motor deficits-especially action slowing and executive dysfunction-being strong predictors of poor recovery outcomes. Recent advances in network neuroscience suggest that action speed is governed by interactions between specific prefrontal and premotor regions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- The control group consists of individuals who are :
- neurologically healthy,
- meaning they do not have any medical conditions that could interfere with cognitive performance or its measurement.
- not have any contraindications for undergoing MRI scans or TMS, such as epilepsy, which could be triggered by magnetic stimulation.
- The patient group will include :
You likely can't join if
- participants with neurological,
- psychiatric, or general conditions known to alter test performance or cognitive function, according to a previously validated method will be excluded.
- any contraindication to MRI and TMS (e.g., epilepsy).
- For stroke patients, the lesion delineated on MRI must spare the prefrontal target structures.
See the full eligibility criteria
- The control group consists of individuals who are :
- neurologically healthy,
- meaning they do not have any medical conditions that could interfere with cognitive performance or its measurement.
- not have any contraindications for undergoing MRI scans or TMS, such as epilepsy, which could be triggered by magnetic stimulation.
- The patient group will include :
- individuals who have experienced a hemispheric stroke but with specific criteria ( stroke must not have affected key prefrontal regions that are targeted in the study, ensuring that the observed motor slowing is due to...
- be free of other cognitive impairments or medical conditions that could confound the study's results.
- participants with neurological,
- psychiatric, or general conditions known to alter test performance or cognitive function, according to a previously validated method will be excluded.
- any contraindication to MRI and TMS (e.g., epilepsy).
- For stroke patients, the lesion delineated on MRI must spare the prefrontal target structures.
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, Picardie, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, Picardie, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.